Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-547,632 in Recurrent Ovarian Cancer
NCT00096239Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CP-547632 in ovarian cancer, primary peritoneal cancer (PPC), fallopian tube cancer (PFTC), sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Dec 2004; status: completed.
02
Drugs
CP-547632
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT00096239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00096239.